| Literature DB >> 32655267 |
Xiao Meng1, Guo-Yi Tang2, Cai-Ning Zhao2, Qing Liu2, Xiao-Yu Xu2, Shi-Yu Cao2.
Abstract
BACKGROUND: Alcoholic liver disease (ALD) is a worldwide health problem, and natural products have been shown to improve ALD due to their antioxidant activities. Some parts of Hovenia dulcis (H. dulcis), such as roots, peduncles, and stems, provide health benefits. Nevertheless, the effects and mechanisms of H. dulcis seeds on ALD have not yet been fully elucidated. AIM: To determine H. dulcis antioxidant activity, evaluate its effects against ALD, and investigate the related mechanisms via network pharmacology.Entities:
Keywords: Hovenia dulcis; Alcoholic liver disease; Antioxidant activity; Hepatoprotection; Network pharmacology; Oxidative stress
Mesh:
Substances:
Year: 2020 PMID: 32655267 PMCID: PMC7327782 DOI: 10.3748/wjg.v26.i24.3432
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Ferric-reducing antioxidant power, trolox equivalent antioxidant capacity, total phenol content, and total flavonoid content values of Hovenia dulcis seeds
| 245.11 ± 10.17 | 284.35 ± 23.57 | 6.29 ± 0.56 | 2.25 ± 0.17 | 0.03 ± 0.00 |
FRAP: Ferric-reducing antioxidant power; TEAC: Trolox equivalent antioxidant capacity; TPC: Total phenol content; TFC: Total flavonoid content; PSC: Polysaccharide content; DW: Dried weight.
Effects of Hovenia dulcis seeds on serum biomarkers
| Control | 28.43 ± 4.27 | 118.19 ± 8.38 | 1.84 ± 0.26 | 1.30 ± 0.12 |
| Model | 44.14 ± 3.47 | 141.23 ± 5.39 | 2.50 ± 0.37 | 1.85 ± 0.25 |
| Treatment | 32.57 ± 5.69 | 123.91 ± 11.09 | 2.19 ± 0.21 | 1.42 ± 0.21 |
P < 0.05,
P < 0.01 vs control group.
P < 0.05,
P < 0.01 vs model group. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; sTG: Serum triglyceride.
Figure 1Effects of Hovenia dulcis seeds on hepatic biomarkers in mice with alcoholic liver injury. A: Superoxide dismutase; B: Catalase; C: Glutathione; D: Malondialdehyde; E: Hepatic triglyceride. aP < 0.05, bP < 0.01 vs control group; cP < 0.05, dP < 0.01 vs model group. Error bars: standard deviations (n = 8). H. dulcis: Hovenia dulcis; SOD: Superoxide dismutase; CAT: Catalase; GSH: Glutathione; MDA: Malondialdehyde; hTG: Hepatic triglyceride.
Figure 2Histopathological changes (magnified × 400 times, stained by hematoxylin and eosin). A: Control group; B: Model group; C: Hovenia dulcis seed group. Scale bar: 50 μm; Oval: Area with lipid droplets; Arrow: Inflammatory cells.
Figure 3Protein–protein interaction network and node degrees. A: Interaction of 173 common target proteins; B: Thirty targets with the highest node degrees.
Figure 4Complex interaction network between targets, the eligible ingredients, and alcoholic liver disease. A: Perlolyrine; B: β-sitosterol; C: Kaempferol; D: Naringenin; E: Stigmasterol; F: Quercetin. ALD: Alcoholic liver disease; H. dulcis: Hovenia dulcis.
Figure 5Top 20 enriched biological processes from gene ontology analysis. FDR: False discovery rate.
Figure 6Top 20 enriched pathways from Kyoto Encyclopedia of Genes and Genomes analysis. FDR: False discovery rate.